NCT05659186 2022-12-21
PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid Cancer
West China Hospital
Phase 2 Unknown
Clinical Trials
5 trialsNCT04999800 2021-08-11
Study of Pembrolizumab Combined With Anlotinib in the First Line Therapy for R/M HNSCC With CPS≥1
ChineseAMS
Phase 2 Unknown
NCT04309136 2021-04-01
Anlotinib Neoadjuvant Treatment in Locally Advanced Thyroid Cancer
Fudan University
Phase 2 Unknown
NCT02586337 2019-05-21
Study of Anlotinib in Patients With Differentiated Thyroid Cancer(ALTER01032)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2/3 Unknown
NCT03639467 2018-09-18
Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal Carcinoma
ChineseAMS
Phase 1/2 Unknown